Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 806 results for "pfizer drugmaker pfizer"

Pfizer to acquire Hospira in big pharma sale
Digital Journal

Pfizer to acquire Hospira in big pharma sale

Major drugs company Pfizer has agreed to buy Illinois-based Hospira, which is a major manufacturer of injectable drugs, infusion technologies, and biosimilars, for $90 a share. This represents the first major acquisition for Pfizer after its attempt ... Digital Journal, 1 month ago

16 images for pfizer drugmaker pfizer

Citybizlist, 2 weeks ago
Pharmaceutical Technology, 3 weeks ago
One News Page United Kingdom, 1 month ago
Irish Independent, 1 month ago
Citybizlist, 1 month ago
Malaysian Insider, 1 month ago, 2 months ago
Chicago Sun-Times, 1 month ago
CNBC, 1 month ago
Asiaone, 2 months ago

Why Pfizer Inc. Isn't Built to Last

Source: Wikimedia. Nearly all big pharma these days have been undergoing wholesale changes due to the patent cliff, the emergence of game-changing new classes of drugs, and payers leveraging their formularies to induce pricing wars. A direct ...
 Nasdaq1 week ago Pfizer Says Phase 4 Lyrica Study Fails To Meet Main Goal  RTTNews.com2 weeks ago Did Pfizer Inc. Just Gut Its Chances of Finding New Blockbusters?  Motley Fool2 weeks ago Pfizer developing PCSK9 pill, vaccine to lower cholesterol  Reuters2 months ago
Healthcare Finance News

Pfizer CEO Ian Read's 2014 Compensation Rises 23% To $23.3 Mln

Pharmaceutical giant Pfizer, Inc. (PFE: Quote) revealed in a regulatory filing on Thursday that Chairman and Chief Executive Officer Ian Read received a 2014 total compensation that grew 23 percent from last year, reflecting strong increase in ...
 RTTNews.com2 weeks ago Hospira CEO May Walk Away With More Than $80 Million After Pfizer Deal is Finalized  BioSpace1 month ago Pfizer Not Done With Deals Even After Hospira Purchase: Real M  La Repubblica1 month ago Hospira may be just the tip of the iceberg for deal-hungry Pfizer  FiercePharma1 month ago
Pharmaceutical Technology

Pfizer obtains EC approval for pneumococcal vaccine Prevenar 13

US drugmaker Pfizer has received expanded approval from the European Commission (EC) for its Prevenar 13 (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), to prevent pneumonia caused by the 13 pneumococcal serotypes in the ...
 Pharmaceutical Technology3 weeks ago Pfizer planning R&D job cuts in response to "shifting priorities"  FirstWord Pharma1 month ago Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 billion  Reuters2 months ago MSF slams expensive vaccines, urges GSK and Pfizer to cut prices  Reuters2 months ago

Pfizer Inc. (PFE) Strikes A $5 Billion Accelerated Share Repurchase Deal With Goldman Sachs Group Inc

Pfizer Inc. ( NYSE:PFE ) announced it has entered into an accelerated share repurchase (ASR) agreement with Goldman, Sachs & Co. to buy back $5 billion worth of the company's common stock. This repurchase decision is part of the company's ASR ...
 Bidness Etc1 month ago Pfizer Entered Into $5 Bln Accelerated Share Repurchase Agreement  RTTNews.com1 month ago
Channel NewsAsia

Pfizer in US$5b accelerated buyback deal

REUTERS: Drugmaker Pfizer Inc said it entered into an agreement with Goldman, Sachs & Co to buy back US$5 billion of its stock. Pfizer said the accelerated share repurchase was assumed in the forecast for the full year it provided last month. ...
 Channel NewsAsia1 month ago Pfizer in $5 bln accelerated buyback deal with Goldman, Sachs & Co  CNBC1 month ago Pfizer in US$5 billion accelerated buyback deal with Goldman, Sachs & Co  Channel NewsAsia1 month ago Pfizer in $5 billion accelerated buyback deal with Goldman, Sachs & Co  Yahoo! UK and Ireland1 month ago
Seeking Alpha

PFIZER : Block & Leviton LLP Investigates Hospira, Inc. for Possible Breaches of Fiduciary Duty in Connection with Their Proposed Acquisition by Pfizer...

Block & Leviton LLP Investigates Hospira, Inc. for Possible Breaches of Fiduciary Duty in Connection with Their Proposed Acquisition by Pfizer Inc. By a News Reporter-Staff News Editor at Biotech Week -- Block & Leviton LLP (, a ...
 4 Traders1 month ago Pfizer Pays A Pretty Penny For Hospira: Here's What You Need To Know  Seeking Alpha1 month ago Pfizer To Buy Hospira For $15.23 Bln  RTTNews.com1 month ago Hospira : UPDATE: Pfizer Inc To Buy Hospira Inc For USD15.23 Billion  4 Traders1 month ago

Will Pfizer Inc. Break Up in 2015?

The pharma giant's stock is seemingly stuck in a rut, largely because of the loss of exclusivity for former top sellers such as Celebrex and Lipitor. But the truth is slightly more complex. Pfizer has been churning out major new products such as ...
 Motley Fool1 month ago Pfizer Flexes Muscle With Priciest Purchase of Decade  Yahoo! Finance1 month ago
Motley Fool

Pssst... Pfizer Just Told Investors That This is the Next Big Thing

Pfizer's vote of confidence in biosimilars -- the generic alternatives to biologic-based medicines such as AbbVie's megablockbuster drug Humira -- isn't misplaced. According to Frost & Sullivan, the biosimilar market is expected to surge from just ...
 Motley Fool1 month ago
Motley Fool

Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?

After being spurned repeatedly by British drugmaker AstraZeneca, Pfizer recently anted up $17 billion for a much smaller drug company, Hospira (NYSE: HSP While the acquisition surprised almost everyone, I think it's a savvy move. Hospira will allow ...
 Motley Fool1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less